Ferrajoli A et al. The combination of lenalidomide and rituximab induces complete and partial responses in patients with relapsed and refractory chronic lymphocytic leukemia. Proc ASH 2010;Abstract 1395.

Shanafelt T et al. Lenalidomide consolidation after first-line chemoimmunotherapy for patients with previously untreated CLL. Proc ASH 2010;Abstract 1379.

Dr Cheson is Professor of Medicine, Head of Hematology and Director of Hematology Research at Georgetown University Hospital’s Lombardi Comprehensive Cancer Center in Washington, DC.